Sunshine Biopharma Inc. (SBFMW) Free cash flow 2016–2025
Sunshine Biopharma Inc. (SBFMW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.5MFY2025 · since FY2016: -$317,621 → -$5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.5M | +61.2% |
| FY2024 | -$14.2M | -60.1% |
| FY2023 | -$8.9M | -62.7% |
| FY2022 | -$5.4M | -197.5% |
| FY2021 | -$1.8M | -177.8% |
| FY2020 | -$658,490 | -32.6% |
| FY2019 | -$496,658 | +6.6% |
| FY2018 | -$531,656 | +2.8% |
| FY2017 | -$547,238 | -72.3% |
| FY2016 | -$317,621 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net incomeSBFMW Net marginSBFMW Gross profitSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Operating cash flowSBFMW Capital expendituresSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →